AUC	Area under the curve
CD	Cluster of differentiation
CI	Confidence interval
CNS	Central nervous system
CSF	Cerebrospinal fluid
DMT	Disease-modifying treatments
EDSS	Expanded Disability Status Scale
ELISA	Enzyme-linked immunosorbent assay
FACS	Fluorescence-activated cell sorting
HR	Hazard ratio
IAW	Inflammatory-associated worsening
Ig	Immunoglobulin
ITMS	Intrathecal IgM synthesis
LS-OCMB	Lipid-specific IgM oligoclonal bands
mAb	Monoclonal antibodies
MS	Multiple sclerosis
MRI	Magnetic resonance imaging
OCB	Oligoclonal bands
PIRA	Progression independent of relapse activity
PM	Personalized medicine
PwMS	Patients with multiple sclerosis
RAW	Relapse-associated worsening
ROC	Receiver operating characteristic
sNfL	Serum neurofilament light chain
sGFAP	Serum glial fibrillary acidic protein
T-reg	Regulatory T cells